New Key Statistics Module, Z-Score and F-Score
NAS:MDGL Key Ratios
| Market Cap $ M | 12,493.09 |
| Enterprise Value $ M | 12,010.18 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 74.95 |
| Price/Book | 23.86 |
| Price/Sales | 10.81 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,283.00 |
| EPS (TTM) $ | -12.89 |
| Beneish M-Score | -0.06 |
| 10-y EBITDA Growth Rate % | -13.60 |
| 5-y EBITDA Growth Rate % | -1.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -40.91 |
| EV-to-EBITDA | -41.12 |
| PEG | -- |
| Shares Outstanding M | 23.10 |
| Net Margin (%) | -25.32 |
| Operating Margin % | -25.13 |
| Pre-tax Margin (%) | -25.32 |
| Quick Ratio | 2.94 |
| Current Ratio | 3.20 |
| ROA % (ttm) | -26.61 |
| ROE % (ttm) | -54.34 |
| ROIC % (ttm) | -395.79 |
| Dividend Yield % | -- |
| Altman Z-Score | 8.96 |
MDGL Number of Guru Trades
MDGL Volume of Guru Trades
Gurus Latest Trades with NAS:MDGL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MDGL is held by these investors
Total 3
Madrigal Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:MDGL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers